KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to -$13.2 million.

  • Edwards Lifesciences' Change in Receivables rose 7209.3% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.5 million, marking a year-over-year decrease of 184137.93%. This contributed to the annual value of -$121.2 million for FY2024, which is 18583.57% down from last year.
  • Latest data reveals that Edwards Lifesciences reported Change in Receivables of -$13.2 million as of Q3 2025, which was up 7209.3% from $24.9 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Change in Receivables registered a high of $89.5 million during Q1 2021, and its lowest value of -$105.9 million during Q4 2024.
  • Moreover, its 5-year median value for Change in Receivables was $18.2 million (2023), whereas its average is $13.2 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Change in Receivables soared by 203095.24% in 2021, and later tumbled by 353846.15% in 2024.
  • Edwards Lifesciences' Change in Receivables (Quarter) stood at -$6.8 million in 2021, then surged by 116.18% to $1.1 million in 2022, then soared by 1554.55% to $18.2 million in 2023, then plummeted by 681.87% to -$105.9 million in 2024, then skyrocketed by 87.54% to -$13.2 million in 2025.
  • Its Change in Receivables was -$13.2 million in Q3 2025, compared to $24.9 million in Q2 2025 and $43.7 million in Q1 2025.